Publication:
Osmanicin, a Polyketide Alkaloid Isolated from Streptomyces osmaniensis CA-244599 Inhibits Elastase in Human Fibroblasts.

dc.contributor.authorSamy, Mamdouh N
dc.contributor.authorLe Goff, Géraldine
dc.contributor.authorLopes, Philippe
dc.contributor.authorGeorgousaki, Katerina
dc.contributor.authorGumeni, Sentiljana
dc.contributor.authorAlmeida, Celso
dc.contributor.authorGonzález, Ignacio
dc.contributor.authorGenilloud, Olga
dc.contributor.authorTrougakos, Ioannis
dc.contributor.authorFokialakis, Nikolas
dc.contributor.authorOuazzani, Jamal
dc.date.accessioned2023-01-25T13:35:11Z
dc.date.available2023-01-25T13:35:11Z
dc.date.issued2019-06-15
dc.description.abstractThe strain Streptomyces osmaniensis CA-244599 isolated from the Comoros islands was submitted to liquid-state fermentation coupled to in situ solid-phase extraction with amberlite XAD-16 resin. Elution of the trapped compounds on the resin beads by ethyl acetate afforded seven metabolites, osmanicin (1), streptazolin (2), streptazone C (3), streptazone B1 (4), streptenol C (5), nocardamine (6) and desmethylenylnocardamine (7). Osmanicin (1) is a newly reported unusual scaffold combining streptazolin (2) and streptazone C (3) through a Diels-Alder type reaction. Experimental evidence excluded the spontaneous formation of 1 from 2 and 3. The isolated compounds were evaluated for their ability to inhibit elastase using normal human diploid fibroblasts. Compound 1 exhibited the most potent activity with an IC50 of 3.7 μM.
dc.identifier.doi10.3390/molecules24122239
dc.identifier.essn1420-3049
dc.identifier.pmcPMC6630352
dc.identifier.pmid31208056
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630352/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1420-3049/24/12/2239/pdf?version=1560584916
dc.identifier.urihttp://hdl.handle.net/10668/14131
dc.issue.number12
dc.journal.titleMolecules (Basel, Switzerland)
dc.journal.titleabbreviationMolecules
dc.language.isoen
dc.organizationFundación MEDINA (Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía)
dc.organizationFundación MEDINA
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectStreptomyces osmaniensis
dc.subjectalkaloids
dc.subjectelastase inhibition
dc.subjectin situ solid-phase extraction
dc.subjectosmanicin
dc.subject.meshAlkaloids
dc.subject.meshBiosynthetic Pathways
dc.subject.meshCell Survival
dc.subject.meshDose-Response Relationship, Drug
dc.subject.meshFermentation
dc.subject.meshFibroblasts
dc.subject.meshHumans
dc.subject.meshMagnetic Resonance Spectroscopy
dc.subject.meshModels, Molecular
dc.subject.meshMolecular Conformation
dc.subject.meshMolecular Structure
dc.subject.meshPancreatic Elastase
dc.subject.meshPolyketides
dc.subject.meshRNA, Ribosomal, 16S
dc.subject.meshStreptomyces
dc.titleOsmanicin, a Polyketide Alkaloid Isolated from Streptomyces osmaniensis CA-244599 Inhibits Elastase in Human Fibroblasts.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number24
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6630352.pdf
Size:
2.61 MB
Format:
Adobe Portable Document Format